Quantum-Si incorporated
NGM: QSILive Quote
📈 ZcoreAI Score
Our AI model analyzes Quantum-Si incorporated's price action across multiple timeframes using regression channels and statistical scoring.
Get QSI Z-Score →About Quantum-Si incorporated
Healthcare
Medical Devices
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
📊 Fundamental Analysis
Quantum-Si incorporated demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported -62.2% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -46.5%, which indicates that capital utilization is currently under pressure.
At a current price of $0.74, QSI currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $0.69 - $3.10).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$160.22M
Trailing P/E
--
Forward P/E
-2.00
Beta (5Y)
3.09
52W High
$3.10
52W Low
$0.69
Avg Volume
3.82M
Day High
Day Low